SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011; 124: 192735.
  • 2
    Strandberg LS, Ambrosi A, Jagodic M, Dzikaite V, Janson P, Khademi M, et al. Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block. J Immunol 2010; 185: 357482.
  • 3
    Buyon J. Neonatal lupus. In: Lahita RG, Tsokos G, Buyon JP, Koike T, editors. Systemic lupus erythematosus. 5th ed. San Diego: Academic Press; 2011. p. 54171.
  • 4
    Clancy RM, Marion MC, Kaufman KM, Ramos PS, Adler A, Harley JB, et al, and the International Consortium on Systemic Lupus Erythematosus Genetics. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum 2010; 62: 341524.
  • 5
    Clancy RM, Alvarez D, Komissarova E, Barrat FJ, Swartz J, Buyon JP. Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. J Immunol 2010; 184: 214855.
  • 6
    Armstrong DL, Reiff A, Myones BL, Quismorio FP Jr, Klein-Gitelman M, McCurdy D, et al. Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun 2009; 10: 44656.
  • 7
    Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN, Jackson AU, et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 2008; 57: 313644.
  • 8
    Montpetit ML, Stocker PJ, Schwetz TA, Harper JM, Norring SA, Schaffer L, et al. Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci U S A 2009; 106: 1651722.
  • 9
    Ross RS, Borg TK. Integrins and the myocardium. Circ Res 2001; 88: 11129.
  • 10
    Chen X, Whiting C, Borza C, Hu W, Mont S, Bulus N, et al. Integrin α1β1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor γ-dependent caveolin-1 expression. Mol Cell Biol 2010; 30: 304858.
  • 11
    Chen X, Moeckel G, Morrow JD, Cosgrove D, Harris RC, Fogo AB, et al. Lack of integrin α1β1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 2004; 165: 61730.
  • 12
    Borza CM, Chen X, Mathew S, Mont S, Sanders CR, Zent R, et al. Integrin α1β1 promotes caveolin-1 dephosphorylation by activating T cell protein-tyrosine phosphatase. J Biol Chem 2010; 285: 4011424.
  • 13
    Ivarsson M, McWhirter A, Black CM, Rubin K. Impaired regulation of collagen pro-α 1(I) mRNA and change in pattern of collagen-binding integrins on scleroderma fibroblasts. J Invest Dermatol 1993; 101: 21621.
  • 14
    Kraus DM, Elliott GS, Chute H, Horan T, Pfenninger KH, Sanford SD, et al. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 2006; 176: 441930.
  • 15
    Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000; 287: 498501.